Treatment with a biological product within 12 weeks or 5 half-lives, whichever is longer, prior to Day 1

Treatment with any of the following medications or therapies within 4 weeks or 5 half-lives, whichever is longer, prior to Day 1:

* Systemic corticosteroids

* Systemic immunosuppressants

* Phototherapy

* Janus kinase inhibitors

Treatment with any of the following medications or therapies within 1 week, prior to Day 1:

* TCS of any potency

* TCI

* Topical phosphodiesterase type 4 inhibitors

* Other topical immunosuppressive agents

* Combination topical agents including TCS of any potency, TCI, PDE4 inhibitors, or other topical immunosuppressive agents

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)